GHK-Cu
Copper Tripeptide-1 (cosmetic ingredient)
Topical GHK-Cu has weak, largely industry-linked evidence for skin appearance; there are no human trials of systemic/injectable use, and the key reviews carry undisclosed commercial conflicts.
How confident is BioSignal?
Our overall position, and how sure we are of it across each dimension — including where we are not sure at all.
Limited evidence
Topical GHK-Cu has weak, largely industry-linked evidence for skin appearance; there are no human trials of systemic/injectable use, and the key reviews carry undisclosed commercial conflicts.
Early or sparse human evidence; conclusions remain uncertain.
Human Evidence
Small topical cosmetic studies; no systemic/injectable outcome RCTs.
Mechanistic Plausibility
Copper delivery, gene-regulatory and wound-healing actions in preclinical models.
Research Activity
Mostly reviews and cosmetic/preclinical work, concentrated in commercially-affiliated authors.
Safety Profile
Topical cosmetic use generally well-tolerated; injectable/systemic safety unknown.
Consensus
Not an FDA-approved drug; a cosmetic ingredient.
Where the evidence stands today
How mature the science is, what kinds of evidence exist, and — the part nobody else prints — what is still missing.
3/9
steps proven in humans
Evidence-poor
4 steps not demonstrated: Human biomarker / pharmacology · Large human RCTs · Clinical outcomes · Guideline / regulatory support
Guideline / regulatory support
Not shownCosmetic ingredient, not a drug approval.
Clinical outcomes
Not shownNone.
Large human RCTs
Not shownNone.
Small human outcome trials
LimitedSmall, low-quality, industry-linked topical cosmetic studies.
Human safety data
LimitedTopical cosmetic use generally tolerated; injectable unknown.
Human biomarker / pharmacology
Not shownNo systemic human pharmacology.
Animal
ProvenPreclinical wound-healing.
Cell / in vitro
ProvenSkin-cell studies.
Mechanistic plausibility
ProvenCopper delivery / gene-regulatory actions (preclinical).
The bottom line
What we know, what we think, what we don't know — and what would change our mind.
Cosmetic biology
GHK-Cu has preclinical skin-regeneration and wound-healing biology and is a common cosmetic ingredient; small topical studies report improvements in skin appearance.
Weak, conflict-affected
As a topical cosmetic, it may modestly improve skin appearance, but the human evidence is low-quality and conflict-affected; as an injectable/systemic agent it is unproven.
Real benefit and injection safety
Whether topical benefits are real and meaningful, any systemic health effect, and the safety of injection are unknown.
Cosmetic formulation
Cosmetic formulation research; little rigorous clinical work.
What would change the picture
Independent, well-controlled human trials (topical and, separately, systemic) would be needed to grade real effects.
The biggest myth
“Injectable/systemic GHK-Cu has anti-aging or health benefits.”
There are no human systemic/injectable outcome trials.
Ask BioSignal
Still have a question about ghk-cu?
Answers are retrieved from this record and the rest of the knowledge graph — never generated.
Why people take ghk-cu
Popularity is not evidence — but it is not stupid either. This explains the interest on its own terms.
People search GHK-Cu for skin aging, wrinkles, wound healing, and hair. Interest is not evidence: topical cosmetic benefits rest on weak, conflict-affected studies, and injectable 'anti-aging' use has no human trials — the strongest skin evidence is sun protection and retinoids.
If you're here because…
Jump straight to the part of the evidence that answers your question.
Approval, safety and regulatory
What it is approved for, who should be careful, what remains unknown — and the limits of what this evidence can tell you.
Regulatory status
Cosmetic Ingredient (not an approved drug)
Availability
Cosmetic ingredient (topical); unapproved injectable
Sport (WADA)
Not a listed class — requires confirmation
Known safety profile
Topical cosmetic GHK-Cu is generally well-tolerated (possible local irritation); injectable/systemic safety is unknown.
Common issues
- Possible local irritation (topical)
Use caution if
- Anyone considering injection (unstudied)
- Wilson disease / copper-metabolism disorders
- Pregnancy
Long-term unknowns
All injectable/systemic long-term safety.
Limits of this evidence
Human evidence is topical, low-quality, and industry-linked; systemic data absent. Key reviews carry undisclosed commercial conflicts.
Full regulatory and sport detail
- Regulatory approval
- None as a drug; used as a cosmetic ingredient (cosmetics are not FDA premarket-approved).
- Approved indication
- None (drug).
- Investigational
- None active.
- Research chemical
- Injectable/systemic GHK-Cu is unapproved and unregulated.
- Compounding
- Not applicable.
- Sport (WADA)
- Not clearly a prohibited class — requires confirmation at publication.
- Publication note
- Re-confirm regulatory and anti-doping status at publication. The key reviews carry an undisclosed commercial conflict of interest.
Demand, separated from evidence
Every claim people make about this, counted against what the evidence actually showed.
BioSignal evaluated 4 popular claims about ghk-cu.
Here is where each one landed — including the claims of harm, where “not established” is reassuring rather than damning.
- Mixed evidence
- 2
- Not established
- 2
Popularity is not evidence. This is simply a count of every claim BioSignal evaluated on this page, sorted by what the evidence actually showed — the full reasoning behind each verdict is in the Evidence Review below.
Mixed evidence
- Topical GHK-Cu improves skin appearance.
- GHK-Cu is completely safe.
Not established
- Injectable/systemic GHK-Cu has anti-aging or health benefits.
- GHK-Cu is FDA-approved.
The evidence review
Every claim with the reasoning behind its verdict, the doses actually studied, where scientists agree and disagree, and the questions still open.
What people claim
Every popular claim, with BioSignal’s verdict and how confident we are in it. The verdicts are always visible; open any claim to read the evidence behind it.
Topical GHK-Cu improves skin appearance.MixedLimited evidence
Some small studies suggest modest skin benefits, but the evidence is low-quality and heavily industry-linked.
GHK-Cu is FDA-approved.Not establishedModerate confidence
It is a cosmetic ingredient, not an approved drug; injectable GHK-Cu is unapproved.
GHK-Cu is completely safe.MixedCaution
Topical cosmetic use is generally well-tolerated; injectable safety is unknown.
Doses used in human studies
What was actually given to participants in the research. These are descriptions of studies, not recommendations.
Adults (cosmetic)
- Intervention
- Topical GHK-Cu creams/serums
- Dose
- cosmetic concentrations
- Duration
- weeks
- Outcome
- skin appearance (small studies)
- Notes
- Low-quality/industry-linked evidence.
— (systemic)
- Intervention
- Injectable GHK-Cu
- Dose
- None (no outcome trials)
- Duration
- —
- Outcome
- —
- Notes
- No evidence-based systemic dose; unapproved.
Where scientists agree — and don’t
Agreed
- GHK-Cu has real copper-binding and preclinical skin-repair biology; it is used cosmetically
Debated
- Whether topical clinical benefits are real and meaningful given weak, conflicted evidence
Unknown
- All systemic/injectable effects and safety
What remains unknown
- Do topical benefits replicate in independent, high-quality trials?
- Is there any systemic health effect of injected GHK-Cu?
- What is the injectable safety and product quality?
Questions people actually ask
Does GHK-Cu reverse skin aging?
Topical GHK-Cu may modestly improve skin appearance, but the evidence is small, low-quality, and comes largely from commercially-affiliated authors. Injectable 'anti-aging' use has no human trials. Sun protection and retinoids have far stronger evidence.
Is injectable GHK-Cu safe?
Unknown — there are no human trials of injected GHK-Cu, and it is unapproved and unregulated.
Practical takeaways
- GHK-Cu is a cosmetic peptide with plausible biology but weak, conflict-affected human evidence.
- Topical use may modestly help skin appearance — treat claims with skepticism.
- Injectable/systemic GHK-Cu is unproven and unapproved; no human outcome trials exist.
- The influential reviews carry undisclosed commercial conflicts — interpret cautiously.
- For skin aging, the strongest evidence is sun protection and retinoids, not copper peptides.
How it works
The mechanism comes last on purpose. A compelling explanation of how something might work is the easiest part of the story to tell, and the part most likely to outlive the evidence for it.
How we found out
2015 — Pickart (review)
GHK peptide in skin regeneration.
2018 — Pickart & Margolina (review)
Gene-regulatory actions of GHK-Cu.
Ongoing
No independent systemic human outcome trials.
References
Verified sources. BioSignal does not print a citation it has not checked.
- 01
Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data
Int J Mol Sci 19(7):1987 · 2018
- 02
GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration
Biomed Res Int 2015:648108 · 2015
Version history
1.0
Initial review-hardened record (Experimental; Insufficient/Caution; COI-flagged). Review cadence: Annual.
Continue exploring
Three places this record leads next.